About Timothy Barabe
Timothy Barabe is a director at Heartflow.
Form D filings name Timothy Barabe as a director at HeartFlow Holding.
Timothy Barabe reports to the SEC as a director or officer of 7 public companies, including Cartesian Therapeutics (RNAC), Veeva Systems (VEEV) and Arqule (ARQL).
Timothy Barabe first appears on SEC filings in 2006.
Experience
This experience comes from SEC filings. The years are when the filings name Timothy Barabe in the role, so the role may have started earlier or lasted longer.
HI
Heartflow, Inc.
Director
2025 – 2026 · Public company (HTFL)
CI
Cartesian Therapeutics, Inc.
Director
2016 – 2026 · Public company (RNAC)
VI
Veeva Systems Inc.
Director
2015 – 2021 · Public company (VEEV)
AI
Arqule Inc.
Director
2006 – 2020 · Public company (ARQL)
AI
Acer Therapeutics Inc.
Director
2014 – 2016 · Public company (ACER)
AI
Affymetrix Inc.
Chief Financial Officer
2010 – 2013 · Public company (AFFX)
HI
Human Genome Sciences Inc.
Chief Financial Officer
2006 – 2010 · Public company (HGSI)
Key Colleagues at Startups
The people Timothy Barabe works with at each company, as listed on that company's latest Form D.
HeartFlow Holding, Inc. · Form D, Apr 11, 2025
JL
Jeff Lightcap
Director
CT
Casey Tansey
Director
CT
Charles Taylor
Director
JF
John Farquhar
Executive officer and director
ND
Nicholas Downing
Director
LS
Lonnie Smith
Director
VV
Vikram Verghese
Chief Financial Officer
JC
Julie Cullivan
Director
WW
William Weldon
Director
WR
Wayne Riley
Director